MILLENNIUM MANAGEMENT LLC

Position in CRSP — CRISPR Therapeutics AG

CIK 1273087 NEW YORK, NY

Back to CRSP Full portfolio

Position in CRSP

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$17,942,357

+$16,343,357 QoQ

Shares Held

377,178

+1137.0% QoQ

Ownership

0.391%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

23 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Derivatives in CRSP

reported options exposure · as of Sep 30, 2024

CallValue

$1,550,340

CallShares

33,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. CRSP ranks #61 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	1,262,511	$238,677,704
2	INSM	INSMED Inc	1,157,786	$189,321,166
3	BMRN	Biomarin Pharmaceutical Inc	3,010,308	$170,052,298
4	TERN	Terns Pharmaceuticals, Inc.	3,011,558	$158,769,337
5	ALNY	Alnylam Pharmaceuticals, Inc.	447,887	$148,192,371
6	FOLD	AMICUS THERAPEUTICS, INC.	7,908,459	$114,356,317
7	ARDX	Ardelyx, Inc.	17,842,370	$106,875,796
8	BLTE	Belite Bio, Inc	570,088	$90,894,830

All Filings in CRSP

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,942,357	377,178	+1137.0%	Shares	Sole	2026-05-15
2025-12-31	$1,599,000	30,492	-64.7%	Shares	Sole	2026-02-17
2025-09-30	$5,591,936	86,282	+23.1%	Shares	Sole	2025-11-14
2025-06-30	$3,409,323	70,093	-88.0%	Shares	Sole	2025-08-14
2025-03-31	$19,864,433	583,733	+6769.1%	Shares	Sole	2025-05-15
2024-12-31	$334,481	8,498	-74.2%	Shares	Sole	2025-02-14
2024-09-30	$1,550,340	33,000	-70.0%	Call	Sole	2024-11-14
2024-09-30	$5,171,793	110,085	+318.2%	Shares	Sole	2024-11-14
2024-06-30	$1,421,867	26,326	+749.2%	Shares	Sole	2024-08-14
2024-03-31	$211,296	3,100	-97.1%	Call	Sole	2024-05-15
2024-03-31	$7,200,626	105,643	+511.7%	Shares	Sole	2024-05-15
2023-12-31	$1,081,102	17,270	-87.3%	Shares	Sole	2024-02-14
2023-09-30	$6,183,479	136,230	+118.9%	Shares	Sole	2023-11-14
2023-06-30	$3,494,546	62,247	+23.3%	Shares	Sole	2023-08-14
2023-06-30	$2,835,070	50,500	-78.0%	Call	Sole	2023-08-14
2023-03-31	$10,401,859	229,977	+666.6%	Shares	Sole	2023-05-15
2023-03-31	$1,356,900	30,000	+147.0%	Call	Sole	2023-05-15
2022-12-31	$493,653	12,144	+26.4%	Shares	Sole	2023-02-14
2022-09-30	$628,078	9,611	-51.9%	Shares	Sole	2022-11-14
2022-06-30	$1,215,400	20,000	-56.3%	Call	Sole	2022-08-15
2022-03-31	$2,874,112	45,788	+114.0%	Shares	Sole	2022-05-16
2022-03-31	$1,343,278	21,400	-94.5%	Call	Sole	2022-05-16
2021-12-31	$29,240,925	385,866	+1303.1%	Shares	Sole	2022-02-14
2021-12-31	$2,083,950	27,500	-8.3%	Call	Sole	2022-02-14
2021-09-30	$3,357,900	30,000	-84.4%	Call	Sole	2021-11-15
2021-09-30	$21,456,981	191,700	+669.9%	Shares	Sole	2021-11-15
2021-06-30	$4,031,061	24,900	-73.1%	Call	Sole	2021-08-16
2021-06-30	$14,997,327	92,639	+3760.0%	Shares	Sole	2021-08-16
2021-06-30	$388,536	2,400	-68.0%	Put	Sole	2021-08-16
2021-03-31	$913,875	7,500	-66.7%	Put	Sole	2021-05-17
2021-03-31	$2,741,625	22,500	-78.2%	Call	Sole	2021-05-17
2021-03-31	$12,564,197	103,112	+364.8%	Shares	Sole	2021-05-17
2020-12-31	$3,396,745	22,185	-44.5%	Shares	Sole	2021-02-16
2020-12-31	$6,124,400	40,000	+94.3%	Call	Sole	2021-02-16
2020-06-30	$1,513,306	20,592	-17.6%	Shares	Sole	2020-08-14
2020-06-30	$1,837,250	25,000	—	Call	Sole	2020-08-14
No filing history on record for this holder in this stock.